Hendrix Genetics' adoption of the Genus Focus for in-ovo sexing at its new hatchery in Germany marks a significant leap in the poultry industry's technological advancements. This innovative approach not only enhances operational efficiency but also aligns with stringent animal welfare standards, making it a win-win solution for both the company and the industry as a whole.
The decision to collaborate with Orbem and Vencomatic Group underscores Hendrix Genetics' commitment to partnering with industry leaders to leverage cutting-edge solutions. By incorporating the Genus Focus, which utilizes Magnetic Resonance Imaging (MRI) technology, Hendrix Genetics can offer in-ovo sexed day-old layer chicks to markets in Germany and the Netherlands, further bolstering its position as a key player in the poultry sector.
The emphasis on automation and non-invasiveness in the Genus Focus reflects the industry's ongoing efforts to balance efficiency with ethical considerations. This technology not only streamlines the sex determination process but also ensures compliance with animal welfare regulations, including those outlined by the German Association for Controlled Alternative Animal Husbandry (KAT).
Dr. Pedro Gomez's acknowledgment of HGL Deutschland's adoption of the Genus Focus as a significant industry advancement highlights the transformative potential of this technology. By embracing AI-powered MRI technology, Hendrix Genetics is spearheading a new era of in-ovo sexing, setting a precedent for future innovation and sustainability in poultry breeding.
Overall, this collaboration underscores Hendrix Genetics' commitment to driving progress in the poultry industry while prioritizing animal welfare and sustainability.
